PARTIKULA
Partikula utilizes its proprietary chemical engineering technologies to develop compounds that specifically and directly target mitochondria, from the outer mitochondrial membrane to the mitochondrial matrix and areas in between. By utilizing their technologies they can now access a large number of important and in some cases well-studies targets that until now have been difficult to target with traditional therapies. Their initial clinical focus is in oncology although they do have programs in earlier stages of development in the areas of neurodegenerative, cardiovascular, and orphan mitochondrial disease.
PARTIKULA
Industry:
Biotechnology Developer Platform Medical
Founded:
2013-01-01
Address:
Davie, Florida, United States
Country:
United States
Website Url:
http://www.partikula.com
Total Employee:
1+
Status:
Active
Contact:
(305) 482-3760
Total Funding:
550 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Nginx Google Apps For Business Nginx 1.14 Hover OpenSRS
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Founder
Official Site Inspections
http://www.partikula.com
- Host name: 216.40.34.41
- IP address: 216.40.34.41
- Location: Mississauga Canada
- Latitude: 43.5898
- Longitude: -79.7599
- Timezone: America/Toronto
- Postal: L5N
